INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 3 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $754,472 | -19.3% | 14,484 | -1.9% | 0.00% | -60.0% |
| Q2 2023 | $935,110 | +9.1% | 14,768 | -6.7% | 0.01% | +150.0% |
| Q1 2023 | $856,924 | +22.7% | 15,825 | +19.9% | 0.00% | 0.0% |
| Q4 2022 | $698,226 | +51.8% | 13,194 | +33.4% | 0.00% | +100.0% |
| Q3 2022 | $460,000 | +83.3% | 9,888 | +124.6% | 0.00% | 0.0% |
| Q2 2022 | $251,000 | -3.5% | 4,403 | +3.6% | 0.00% | 0.0% |
| Q1 2022 | $260,000 | – | 4,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |